臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"lin c c"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 1296-1320 / 2549 (共102頁)
<< < 47 48 49 50 51 52 53 54 55 56 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-05-26T09:27:03Z	First-line management of EGFR-mutated advanced lung adenocarcinoma: Recent developments	Liao B.-C;Lin C.-C;Chih-Hsin Yang; Liao B.-C; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:02Z	EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer	Kao H.-F;Lin C.-C;Chih-Hsin Yang; Kao H.-F; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:00Z	Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer	Lee J.-H; Lin Y.-L; Hsu W.-H; Chen H.-Y; Chang Y.-C; Yu C.-J; Shih J.-Y; Lin C.-C; Chen K.-Y; Ho C.-C; Laio W.-Y; Yang P.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:00Z	A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors	Ghamande S; Lin C.-C; Cho D.C; Shapiro G.I; Kwak E.L; Goel S.; Chuadhary I; Ghalib M.H; Cheng A.-L; CHIH-HSIN YANG; Coleman T; Silverman M.H; Tseng Y; Kuo M.-W; Mach W.B; Hsu S.-C
臺大學術典藏	2020-05-26T09:26:59Z	First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trial	CHIH-HSIN YANG; Kang J.H; Mok T; Ahn M.-J; Srimuninnimit V; Lin C.-C; Kim D.-W; Tsai C.-M; Barraclough H; Altug S; Orlando M; Park K.
臺大學術典藏	2020-05-26T09:26:57Z	A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies	Lin C.-C;Su W.-C;Yen C.-J;Hsu C.-H;Su W.-P;Yeh K.-H;Lu Y.-S;Cheng A.-L;Huang D.C.-L;Fritsch H;Voss F;Taube T;Chih-Hsin Yang; Lin C.-C; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; Lu Y.-S; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:55Z	Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer	Chih-Hsin Yang;Lin C.-C;Liao B.-C; Liao B.-C; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:55Z	Treating patients with ALK-positive non-small cell lung cancer: Latest evidence and management strategy	Chih-Hsin Yang;Shih J.Y;Lin C.C;Liao B.C; Liao B.C; Lin C.C; Shih J.Y; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:52Z	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis	Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Ho C.-C;Chang C.-H;Chen Y.-F;Lin C.-C;Lee J.-H;Liao B.-C; Liao B.-C; Lee J.-H; Lin C.-C; Chen Y.-F; Chang C.-H; Ho C.-C; Shih J.-Y; Yu C.-J; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:48Z	Gefitinib maintenance therapy versus gefitinib monotherapy in east asian never-smoker patients with locally advanced or metastatic nonsquamous non-small cell lung cancer: Final overall survival results from a randomized phase 3 study	Park K.;Wang X;Puri T;Orlando M;Mok T;Tsai C.-M;Kim S.-W;Lin C.-C;Ahn M.-J;Srimuninnimit V;Chih-Hsin Yang; CHIH-HSIN YANG; Srimuninnimit V; Ahn M.-J; Lin C.-C; Kim S.-W; Tsai C.-M; Mok T; Orlando M; Puri T; Wang X; Park K.
臺大學術典藏	2020-05-26T09:26:47Z	151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs	Chih-Hsin Yang;Yu C.-J;Chang Y.-C;Shih J.-Y;Ho C.-C;Lee Y.-F;Lin S.-Y;Lin C.-C;Bai Y.-Y;Liao B.-C; Liao B.-C; Bai Y.-Y; Lin C.-C; Lin S.-Y; Lee Y.-F; Ho C.-C; Shih J.-Y; Chang Y.-C; Yu C.-J; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:45Z	Safety of gefitinib in non-small cell lung cancer treatment	Chih-Hsin Yang;Lin C.-C;Lee J.-H;Hsiue E.H.-C; Hsiue E.H.-C; Lee J.-H; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:43Z	Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors	Chih-Hsin Yang;Lee J.-H;Lin C.-C;Liao B.-C; Liao B.-C; Lin C.-C; Lee J.-H; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:43Z	Profile of the therascreen® EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer	Chih-Hsin Yang;Lin C.-C;Lee J.-H;Hsiue E.H.-C; Hsiue E.H.-C; Lee J.-H; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:38Z	Osimertinib in pretreated T790M-positive advanced non-small-cell lung cancer: AURA study phase II extension component	J?nne P.A.;Ghiorghiu S;Cantarini M;Mann H;Lin C.-C;Hirashima T;Gold K;Novello S;Yoh K;Haggstrom D;Blackhall F;Felip E;Planchard D;Kim J.-H;Kim S.-W;Su W.-C;Sequist L.V;Ramalingam S.S;Kim D.-W;Ahn M.-J;Chih-Hsin Yang; CHIH-HSIN YANG; Ahn M.-J; Kim D.-W; Ramalingam S.S; Sequist L.V; Su W.-C; Kim S.-W; Kim J.-H; Planchard D; Felip E; Blackhall F; Haggstrom D; Yoh K; Novello S; Gold K; Hirashima T; Lin C.-C; Mann H; Cantarini M; Ghiorghiu S; Jänne P.A.
臺大學術典藏	2020-05-26T09:26:36Z	Optimal management of EGFR-mutant non-small cell lung cancer with disease progression on first-line tyrosine kinase inhibitor therapy	Chih-Hsin Yang;Lee J.-H;Lin C.-C;Liao B.-C; Liao B.-C; Lin C.-C; Lee J.-H; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:36Z	Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib	Yu C.-J.;Chih-Hsin Yang;Lin C.-C;Lin Z.-Z;Chen J.-S;Shih J.-Y;Chen K.-Y;Ho C.-C;Liao W.-Y;Yao Z.-H; Yao Z.-H; Liao W.-Y; Ho C.-C; Chen K.-Y; Shih J.-Y; Chen J.-S; Lin Z.-Z; Lin C.-C; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2020-05-26T09:26:34Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Yu C.-J.;Chih-Hsin Yang;Shih J.-Y;Lin C.-C;Lee J.-H;Chang Y.-L;Su K.-Y;Hsu W.-H;Hsu C.-L;Tsai T.-H;Chen K.-Y;Liao W.-Y;Ho C.-C;Liao B.-C;Yang C.-Y;Lin S.-Y; Lin S.-Y; Yang C.-Y; Liao B.-C; Ho C.-C; Liao W.-Y; Chen K.-Y; Tsai T.-H; Hsu C.-L; Hsu W.-H; Su K.-Y; Chang Y.-L; Lee J.-H; Lin C.-C; Shih J.-Y; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2020-05-26T09:26:31Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Chih-Hsin Yang;Thress K.S;Huang D.D.-R;Bai Y.-Y;Chang Y.-L;Hsieh M.-S;Su K.-Y;Tsai T.-H;Lee J.-H;Liao W.-Y;Ho C.-C;Yu C.-J;Shih J.-Y;Lin C.-C; Lin C.-C; Shih J.-Y; Yu C.-J; Ho C.-C; Liao W.-Y; Lee J.-H; Tsai T.-H; Su K.-Y; Hsieh M.-S; Chang Y.-L; Bai Y.-Y; Huang D.D.-R; Thress K.S; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:29Z	Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors	Yang P.-C.;Chih-Hsin Chih-Hsin Yang;Yu C.-J;Chang Y.-C;Shih J.-Y;Ho C.-C;Lee Y.-F;Lin S.-Y;Lin C.-C;Lee J.-H;Bai Y.-Y;Liao B.-C; Liao B.-C; Bai Y.-Y; Lee J.-H; Lin C.-C; Lin S.-Y; Lee Y.-F; Ho C.-C; Shih J.-Y; Chang Y.-C; Yu C.-J; Chih-Hsin CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏	2020-05-26T09:26:28Z	Treating brain metastases in non-small cell lung cancer patients: what have we learnt from pharmaceutical recent clinical trials?	Chih-Hsin Yang;Lin C.-C;Liao B.-C; Liao B.-C; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:28Z	Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non?�Small-cell Lung Cancer Patients	Wu T.-H; Hsiue E.H.-C; Lee J.-H; Lin C.-C; Liao W.-Y; Ho C.-C; Shih J.-Y; Yu C.-J; CHIH-HSIN YANG; Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Ho C.-C;Liao W.-Y;Lin C.-C;Lee J.-H;Hsiue E.H.-C;Wu T.-H
臺大學術典藏	2020-05-26T09:26:22Z	Phase I Study of the Focal Adhesion Kinase Inhibitor BI?853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors	Doi T;Chih-Hsin Yang;Shitara K;Naito Y;Cheng A.-L;Sarashina A;Pronk L.C;Takeuchi Y;Lin C.-C.; Doi T; CHIH-HSIN YANG; Shitara K; Naito Y; Cheng A.-L; Sarashina A; Pronk L.C; Takeuchi Y; Lin C.-C.
臺大學術典藏	2020-05-26T09:26:19Z	Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non?�small-cell lung cancer patients	Yao Z.-H;Liao W.-Y;Ho C.-C;Chen K.-Y;Shih J.-Y;Chen J.-S;Lin Z.-Z;Lin C.-C;Chih-Hsin Yang;Yu C.-J.; Yao Z.-H; Liao W.-Y; Ho C.-C; Chen K.-Y; Shih J.-Y; Chen J.-S; Lin Z.-Z; Lin C.-C; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2020-05-26T09:26:18Z	Clinical Outcomes of Up-front Surgery Versus Surgery After Induction Chemotherapy for Thymoma and Thymic Carcinoma: A Retrospective Study	Ma W.-L;Lin C.-C;Hsu F.-M;Lee J.-M;Chen J.-S;Hsieh M.-S;Chang Y.-L;Chao Y.-T;Chang C.-H;Chih-Hsin Yang; Ma W.-L; Lin C.-C; Hsu F.-M; Lee J.-M; Chen J.-S; Hsieh M.-S; Chang Y.-L; Chao Y.-T; Chang C.-H; Chih-Hsin CHIH-HSIN YANG

顯示項目 1296-1320 / 2549 (共102頁)
<< < 47 48 49 50 51 52 53 54 55 56 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52915709 線上人數 : 523 教育部委託研究計畫計畫執行:國立臺灣大學圖書館